No black box warning on record for Flolan

As of the latest FDA labeling reviewed, Flolan (EPOPROSTENOL SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Flolan medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Pulmonary edema: Discontinue therapy if pulmonary edema occurs. ( 5.1 ) • Rebound pulmonary hypertension: Do not abruptly discontinue or decrease the dose. ( 5.2 ) • Vasodilation reactions: Monitor blood pressure and symptoms regularly during initiation and after dose change. ( 5.3 ) • Increased risk for bleeding: Increased risk for hemorrhagic complications, particula

No black box warning on record for Flolan

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Pulmonary edema: Discontinue therapy if pulmonary edema occurs. ( 5.1 ) • Rebound pulmonary hypertension: Do not abruptly discontinue or decrease the dose. ( 5.2 ) • Vasodilation reactions: Monitor blood pressure and symptoms regularly during initiation and after dose change. ( 5.3 ) • Increased risk for bleeding: Increased risk for hemorrhagic complications, particula

Flolan Black Box Warning

No black box warning on record for Flolan

Other warnings & precautions

Flolan Black Box Warning

No black box warning on record for Flolan

Other warnings & precautions